Single use Bioprocessing Market: Growing Demand, Geographical Segmentation, Analysis of Leading Players By 2026

A new research report titled; ‘Global Single use Bioprocessing Market’ has been added into the vast repository of research reports by MarketsandMarkets™ INC. The research report covers a detailed analysis of the overview of the market, overall size, share, product definition, supply chain analysis, supply chain ratio, upstream raw materials and equipment, downstream demand analysis, and import/export details. The report further analyses the different approaches, procedures, strategies, and methodologies adopted by the leading competitors operating in the market to make strategic key business decisions. Apart from the above-mentioned key findings, the report also states the growth rate of the global market, as well as the facts, figures, consumption tables, and statistics of the leading segments. Additionally, the Global Single use Bioprocessing Market research report provides an in-depth study of the current scenario of the market, along with the current and future industry trends, in order to identify the investment analysis.

Single use Bioprocessing Overview:

The global single use bioprocessing market is expected to reach USD 20.8 billion by 2026 from USD 8.2 billion in 2021, at a CAGR of 20.5%

Single-use bioprocessing is a rapidly evolving technology used to develop disposable bioprocessing equipment and accessories to manufacturing biopharmaceutical molecules such as recombinant proteins, monoclonal antibodies, vaccines, and stem cells. Bioprocess utilizes living cells or their components such as enzymes, bacteria, and others to obtain preferred products. The central idea behind using single-use bioprocessing technology in the bioprocess is to decrease the cost associated with complicated steps such as cleaning, sterilization, and maintenance of steel-based bioreactor systems.

Furthermore, the Global Single use Bioprocessing Market Research Report provides the competitive landscape of the market and gathers information with regards to the company overview, contact information, market size and share, company’s headquarters and corporate offices, and sales revenue. The report also discusses the different development plans and policies of the industry, product pictures, and the process of manufacturing the product, production volume, and product draft. Moreover, the report provides an in-depth survey of the industry feasibleness, market strategies, investment return analysis, product volume, supply and demand ratio, market utilization value, and the industry chain value. In the last section of the report, the key distributors, suppliers, distinct traders, as well as the sales and distribution challenge, research findings, data resources, and appendix, have been studied.

Single use Bioprocessing Industry | Key Market Players:

Sartorius Stedim Biotech S.A.  (France), Thermo Fisher Scientific (US), Danaher Corporation (US), Merck KGaA (Germany), Getinge AB (Sweden), Eppendorf AG (Germany), Corning (US), Entegris (US), Avantor (US), CESCO Bioengineering Co. Ltd. (Taiwan), Cellexus (UK), PBS Biotech, Inc. , Distek, Inc. (US), ABEC, Inc. (US), Able Corporation & Biott Corporation (Japan), G&G Technologies (US), Solida Biotech GmbH (Germany), Satake Chemical Equipment Mfg., Ltd. (Japan), Stobbe Pharma GmbH (Switzerland), Celltainer Biotech (Netherlands), Meissner Filtration Products, Inc. (US), bbi-biotech GmbH (Germany), Pierre Guerin (France), Kuhner AG (Switzerland), OmniBRx Biotechnologies (India).

Sartorius Stedim Biotech held the leading position in the single-use bioprocessing market in 2020. Sartorius focuses on strengthening its position in the market by adopting organic and inorganic strategies such as product launches and expansions. During the past three years, Sartorius Stedim Biotech launched SUB systems such as BIOSTAT STR Generation 3 Single-Use Bioreactor, BIOSTAT RM TX Single-Use Bioreactor, and BIOSTAT STR. In 2019, Sartorius acquired Danaher’s Life Science portfolio, which is complementary to the portfolio of Sartorius’s laboratory and bioprocess business. In 2019, the company also expanded their operations in Puerto Rico.

Thermo Fisher Scientific is the second-largest player in the single-use bioprocessing market. Thermo Fisher Scientific operates in the single-use bioprocessing market through the life science solutions business segment. To further increase its share in the single-use bioprocessing market, the company focuses on growth strategies such as acquisitions and expansion. From 2019 to 2021, the company expanded its business in the US. The company also made investments worth ~USD 650 million from 2019 to 2021 to enhance their single-use bioprocessing capabilities and increase their market share.

Media bags and Containers segment accounted for the largest share of the product segment

Based on product, the single-use bioprocessing market is categorized into single-use media bags and containers, single-use assemblies, single-use bioreactors, disposable mixers, and other products. The other products segment includes single-use vessels, tubing, connectors. In 2020, the single-use media bags and containers segment accounted for the largest share of 30.7% of the global single-use bioprocessing market by product. Single-use bioprocessing systems offer benefits such as lower capital investment, lower operating expenses, and lower environmental footprint, thus driving the growing adoption of these systems in biopharmaceutical applications.

The filtration segment accounted for the largest share of the application segment

Based on the application, the single-use bioprocessing market is categorized into five segments based on applications: filtration, mixing, purification, storage, and cell culture. Over the years, technological advancements and the growing adoption of single-use technologies have played a crucial role in widening the applications of single-use bioprocessing systems. Single-use bioprocessing systems are mainly used in upstream and downstream processes in life sciences R&D and biopharmaceutical manufacturing processes.

The filtration segment accounted for the largest share

The global single-use bioprocessing market is categorized into five segments based on applications: filtration, mixing, purification, storage, and cell culture. In 2020, the filtration segment accounted for the largest share of the global single-use bioprocessing market followed by storage application.

North America was the largest regional market for Single use Bioprocessing Market

The single use bioprocessing market is divided into five major regions—North America, Europe, Asia Pacific, Latin America (LATAM), and the Middle East and Africa (MEA). North America accounted for the largest share of this market, followed by Europe in 2020. The increasing demand for biopharmaceuticals is a major factor driving the single-use bioprocessing market in North America. The demand for biopharmaceuticals is rising owing to the growing senior population. The rising demand for biopharmaceuticals and advantages of single-use bioprocessing (such as high energy efficiency, low water usage, less floor space requirement, reduced installation cost, decreased risk of product cross-contamination, and fast implementation) drive the adoption of the single-use bioprocessing market. On the other hand, the high disposable cost and issues related to the transfer of leachables and extractables into the solvent, which can cause contamination, are the major factors restraining the growth of this market.

The Asia Pacific region is the fastest-growing region of the single-use bioprocessing

Based on the region, the single-use bioprocessing market is divided into five major regions—North America, Europe, Asia Pacific, Latin America (LATAM), and the Middle East and Africa (MEA). The single-use bioprocessing market in the APAC, particularly in China, Japan and India, is expected to witness high growth during the forecast period. Growth in these markets will be fueled by significant investments by key market players, increasing government support, developing R&D infrastructure, increasing outsourcing, and growing expertise & academic excellence.

The single-use bioprocessing market is highly consolidated with majority of the market share taken up by key players such as Thermo Fisher Scientific (US), Danaher Corporation (US), Sartorius Stedim Biotech S.A. (France), and Merck KGaA (Germany). The key players in this market are increasingly focusing on strategic expansions, partnerships, and product approvals to expand their manufacturing capabilities and increase market presence.

COVID-19:

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 has since moved from being a regional crisis to a global pandemic. With the World Health Organization (WHO) officially declared the virus outbreak as a pandemic, a mix of established pharmaceutical companies and small startups had stepped forward to develop treatments and vaccines that target the infection caused by the novel coronavirus.

Many biopharmaceutical companies have been rapidly developing vaccines in response to the novel coronavirus pandemic. If these development programs pass the trial phases, the clinical and commercial manufacturing platforms will be largely supported by single-use equipment and systems. Since most of the leading COVID-19 vaccine programs use novel approaches, including mRNA, DNA vaccine, and vectors, these platforms are largely built on single-use systems. Single-use systems are flexible and can quickly be put in place at a lower cost than traditional stainless-steel equipment, which has significant investments and no guarantee of longevity for the future.

Global Single use Bioprocessing Market Dynamics:

• DRIVER: The growing demand for biopharmaceuticals
• RESTRAINT: Issues related to leachables and extractables
• OPPORTUNITY: Emerging markets
• CHALLENGE: Waste disposal

This report categorizes the single use bioprocessing market into the following segments and subsegments:

Product:

• Single-use media bags and containers
• Single-use assemblies
• Single-use bioreactors
• Disposable mixers
• Other products

Application:

• Filtration
• Storage
• Cell culture
• Mixing
• Purification

End user:

• Biopharmaceutical & Pharmaceutical companies
• Contract Research Organizations and contract manufacturing organizations (CROs & CMOs)
• Academic & Research institutes

Some of the key geographies mentioned in this report include:

• North America (U.S and Canada and rest of North America)
• Europe (Germany, France, Italy, and Rest of Europe)
• Asia Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific)
• LAMEA (Brazil, Turkey, Saudi Arabia, South Africa, and Rest of LAMEA)

The research document will answer following questions such as:

• What is the size and share of the global market?
• What are the driving factors of the Global Single use Bioprocessing Market?
• What are the major next-generation techniques/developments stated in the market research report? What are the potential market opportunities of the Global Single use Bioprocessing Market?
• At what stage of development is the Global Single use Bioprocessing Market?
• What are the challenges and threats that the market is facing? Will the market be able to overcome these shortcomings and become commercially viable in the future?
• What are the growth prospects among emerging nations throughout the forecast period?
• Who are the leading competitors functioning in the global market?
• What are the strengths and weaknesses of these leading players?
• What are the market opportunities and recommendations for new investors?

Recent Developments

• In March 2020, Danaher acquired the Biopharma business from General Electric Company’s Life Sciences division. The business is called Cytiva and is a standalone operating company within Danaher’s Life Sciences segment.
• In September 2020, Thermo Fisher Scientific invested more than USD 475 million in new capabilities at its St. Louis site to expand biologics development and manufacturing, cell and gene therapy capabilities, and drug product development capabilities.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high-growth niche opportunities/threats which will impact 70% to 80% of worldwide companies revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their pain points around revenue decisions.

Our 850 full-time analysts and SMEs at MarketsandMarkets™ are tracking global high-growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify the most important customers, write “Attack, avoid and defend” strategies, and identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high-growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them with research ahead of the curve.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road, Suite 430, Northbrook, IL 60062

USA: 1-888-600-6441 | sales@marketsandmarkets.com

More Reports:

Point of Care Molecular Diagnostics Market: https://www.marketsandmarkets.com/Market-Reports/point-of-care-molecular-diagnostic-market-143524127.html

Point-of-care molecular diagnostics market size is projected to reach USD 4.1 billion by 2026 from USD 2.8 billion in 2021, at a CAGR of 8.2%. Growth in the point-of-care molecular diagnostics industry is mainly driven by factors such as the increasing prevalence of infectious diseases and cancer, rising focus on decentralized diagnostics and increasing R&D funding, increasing awareness on the early detection of infectious diseases, and the increasing use of POC diagnostic tests.

Abbott Laboratories (US), F. Hoffmann-La Roche Ltd. (Switzerland) and bioMérieux SA (France) are the Major Players in the Point of Care Molecular Diagnostics Market Report.

Enteral Feeding Devices Market: https://www.marketsandmarkets.com/Market-Reports/enteral-feeding-device-market-183623035.html

Fresenius Kabi (Germany), Nestlé S.A. (Switzerland), Avanos Medical, Inc. (US), B. Braun Melsungen AG (Germany ), and Cardinal Health Inc. (US) are the leading players in the Enteral Feeding Devices Market.